Filtered By:
Condition: Thrombosis
Vaccination: Vaccines
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 939 results found since Jan 2013.
Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem
CONCLUSIONS: VITT is a complication of dose 2 AZD1222 vaccination. Whilst clinicopathological features are less severe, fatalities occurred in patients with concomitant factors.PMID:37085453 | DOI:10.1016/j.vaccine.2023.03.071
Source: Vaccine - April 19, 2023 Category: Allergy & Immunology Authors: Lisa Clarke Timothy Brighton Sanjeev D Chunilal Christine S M Lee Freda Passam Jennifer Curnow Vivien M Chen Huyen A Tran Source Type: research
Fulminant myocarditis following SARS-CoV-2 mRNA vaccination rescued with venoarterial ECMO: A report of two cases
CONCLUSIONS: COVID-19 vaccine-associated fulminant myocarditis has a high morbidity and mortality but presents a high potential for recovery. V-A ECMO should be established in cases with refractory cardiogenic shock during the acute phase.PMID:37075138 | DOI:10.1177/02676591231170480
Source: Perfusion - April 19, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Rosa Vila-Olives Aitor Uribarri Mar ía Martínez-Martínez Eduard Argudo Camilo Bonilla Luis Chiscano Lorena Herrador Alejandra Gabald ón None Irene Buera Maria Vidal Ana De la Iglesia Maria Ángeles Díaz Elena L ópez Marta Font Jose A Barrab és Jord Source Type: research
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms
Res Pract Thromb Haemost. 2023 Feb;7(2):100122. doi: 10.1016/j.rpth.2023.100122. Epub 2023 Mar 15.NO ABSTRACTPMID:36999122 | PMC:PMC10015773 | DOI:10.1016/j.rpth.2023.100122
Source: Thrombosis and Haemostasis - March 31, 2023 Category: Hematology Authors: Oscar Borsani Virginia V Ferretti Ilaria C Casetti Daniele Vanni Chiara Trotti Daniela Pietra Annalisa De Silvestri Luca Arcaini Elisa Rumi Source Type: research
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
CONCLUSION: The incidence of death or thromboembolism was low in this cohort of patients discharged after hospitalization with COVID-19. Because of early enrollment termination, the results were imprecise and the study was inconclusive.PRIMARY FUNDING SOURCE: National Institutes of Health.PMID:36940444 | DOI:10.7326/M22-3350
Source: Annals of Internal Medicine - March 20, 2023 Category: Internal Medicine Authors: Tracy Y Wang Abdus S Wahed Alison Morris Lisa Baumann Kreuziger John G Quigley Gervasio A Lamas Alexandra J Weissman Jose Lopez-Sendon M Margaret Knudson Deborah M Siegal Raj S Kasthuri Andrew J Alexander Lana Wahid Bassel Atassi Peter J Miller Janice W L Source Type: research
TWiV 992: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses clearance of longstanding, immune-deficiency-associated, vaccine-derived poliovirus infection following remdesivir therapy for chronic SARS-CoV-2 infection, SARS-CoV-2 exposure in New York City rats, clinical characteristics and outcomes of children with SARS-CoV-2 infection during the Delta and Omicron variant-dominant periods in Korea, exhaled breath aerosol shedding of SARS-CoV-2 variants, outpatient treatment of COVID-19 and the development of long COVID over 10 months, Nirmatrelvir and the risk of post-acute sequelae of COVID-19, assessment of the risk of venous thr...
Source: This Week in Virology - MP3 Edition - March 18, 2023 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2
CONCLUSIONS: Platelets are a component of the innate immune pathways that promote the B-cell response after vaccination. Future studies on the platelet-immune crosstalk post-immunization will improve safety, efficacy, and strategic administration of next-generation vaccines.PMID:36918114 | DOI:10.1016/j.jtha.2023.03.003
Source: Thrombosis and Haemostasis - March 14, 2023 Category: Hematology Authors: Ludovica Lombardi Francesca Maiorca Ramona Marrapodi Annamaria Sabetta Noemi Scafa Davide Pallucci Marzia Miglionico Giulio F Romiti Bernadette Corica Silvia Piconese Antonella Polimeni Fabio Pulcinelli Roberto Cangemi Marcella Visentini Stefania Basili L Source Type: research
Postmortem PF4 antibodies confirm a rare case of thrombosis thrombocytopenia syndrome associated with ChAdOx1 nCoV-19 anti-COVID vaccination
We report a case of cerebral venous sinus thrombosis, bilateral adrenal hemorrhage, and thrombocytopenia in a 70-year-old man found dead. He had previously received the ChAdOx1 nCoV-19 vaccine (Vaxzevria ®, AstraZeneca) 18 days before, and had since developed unspecific and undiagnosed characteristics of what proved to be a rare case of vaccine-associated thrombocytopenia with thrombosis syndrome (TTS). He was found dead 1 week after the beginning of symptoms (day 25 post-vaccine). Autopsy yielde d venous hemorrhagic infarction with the presence of thrombi within dural venous sinuses, and extensive hemorrhagic necrosis ...
Source: International Journal of Legal Medicine - March 1, 2023 Category: Medical Law Source Type: research
Investigation of Neurological Complications after COVID-19 Vaccination: Report of the Clinical Scenarios and Review of the Literature
Vaccines (Basel). 2023 Feb 13;11(2):425. doi: 10.3390/vaccines11020425.ABSTRACTCoronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), broke out in 2019 and became a pandemic in 2020. Since then, vaccines have been approved to prevent severe illness. However, vaccines are associated with the risk of neurological complications ranging from mild to severe. Severe complications such as vaccine-induced immune thrombotic thrombocytopenia (VITT) associated with acute ischaemic stroke have been reported as rare complications post-COVID-19 vaccination. During the pandemic era, V...
Source: Herpes - February 28, 2023 Category: Infectious Diseases Authors: Wei-Ping Chen Ming-Hua Chen Shih-Ta Shang Yung-Hsi Kao Kuo-An Wu Wen-Fang Chiang Jenq-Shyong Chan Hann-Yeh Shyu Po-Jen Hsiao Source Type: research
